ADmit Therapeutics
un test de diagnóstico precoz para la enfermedad de Alzheimer
Barcelona, Spain · Founded 2017 · $6.5M raised
- Headquarters
- Barcelona
- Founded
- 2017
- Business Model
- B2B
- Website
- admit-therapeutics.com
- Total Funding
- $6.5M
- Last Round
- $6.3M Series AOct 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
ADmit Therapeutics is a Barcelona-based biotechnology company that has developed the MAP-AD® Test, the first CE-IVDR-certified IVD prognostic test for predicting progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia. The test uses AI-powered epigenetic analysis — methylcytosine profiling via next-generation sequencing — combined with age, ApoE genotype, and clinical scores to deliver an early blood-based biomarker with no equivalent in clinical practice. The company serves pharmaceutical firms as an epigenetic patient-selection tool for Alzheimer's clinical trials, emerging from the Bellvitge Biomedical Research Institute and backed by the Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator.
Summary
ADmit Therapeutics is a Biotech company based in Barcelona, Spain, founded in 2017. It has raised $6.5M in total across 2 rounds, most recently a $6.3M Series A round in Oct 2023. Investors include Clave Capital, European Innovation Council Fund and Alzheimer's Drug Discovery Foundation.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2023
Sign up to see all 2 events
Funding: Pre-Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/admit-therapeutics"><img src="https://indexed.vc/api/badge/company/admit-therapeutics" alt="ADmit Therapeutics on Indexed.vc" width="260" height="76" /></a>